Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WD repeat-containing protein 64 (WDR64) is a member of the WD repeat protein family, characterized by the presence of multiple WD40 repeats that typically fold into a β-propeller structure and serve as platforms for reversible protein-protein interactions, rather than possessing any enzymatic or receptor activity[1][2][8]. WDR64 is a human protein encoded by the WDR64 gene and is highly conserved across eukaryotes[3][7][8]. While proteins in this family are implicated in diverse cellular processes—such as signal transduction, cell cycle control, RNA processing, and cytoskeleton organization—the specific biological function and disease relevance of WDR64 itself remain uncharacterized, and there is no evidence linking it directly to therapeutic targeting or known drug interactions[3][8][1]. The current data indicate that its primary molecular role is as a scaffold for multiprotein complex formation without direct catalytic or receptor function[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WD repeat-containing protein 64 (WDR64).